Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_assertion type Assertion NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_head.
- NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_assertion wasGeneratedBy ECO_0000203 NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_provenance.
- NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_assertion wasDerivedFrom befree-20140225 NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_provenance.
- NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_assertion SIO_000772 12118245 NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_provenance.
- NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_assertion evidence source_evidence_literature NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_provenance.
- NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_assertion description "[Most importantly, Smac peptides strongly enhanced the antitumor activity of Apo-2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in an intracranial malignant glioma xenograft model in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166233.RAwjZpHx0prNI0M4H4Y3iljvPaVa416D-TELLmclm4mhM130_provenance.